Beware the quantum computers
Today’s encryption technology will be putty in the hands of those running the post-quantum world. How equipped ...
Suresh Vazirani, Founder & Chairman, Transasia-Erba International Group of Companies
In-vitro diagnostic company, Transasia Bio-Medicals Ltd, has set up a state-of-the-art medical devices manufacturing plant at the Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam, with an investment of ₹30 crore.
The plant was formally inaugurated on Wednesday. Operations will start immediately at this new plant with product rollouts expected in early September.
“The largest-of-its-kind facility in Asia spread over 35,000 sft will manufacture ErbaLisa Covid-19 IgG ELISA test kits, RT-PCR kits and rapid test kits for India and other emerging markets,’’ Suresh Vazirani, Founder & Chairman, Transasia-Erba International Group of Companies, told BusinessLine on Thursday.
Zydus Cadila to make indigenous Covid-19 test kits
This is the fifth manufacturing facility for the Mumbai-based company along with plants in Baddi, Daman, Sikkim and Mumbai.
The facility, with an annual capacity of 2 million Molecular & Serology test kits, has face-recognition system, cold room, storage area, clean rooms of BSL-II/BSL-III grade, large lyophilizers, protein purification equipment, advanced QC equipment and automated machines.
It has the capacity to produce 6 lakh Elisa-based antibody detection test kits per day besides RT-PCR and rapid test kits.
To address the growing need for serological tests as disease prevention, spurred by greater awareness of infectious diseases due to Covid-19, it plans to manufacture testing kits for other immunology products as well.
ICMR approves HiMedia-Syngene’s Elisa test kit for Covid-19
“The facility will play a key role in import substitution of medical devices. It will have the flexibility to scale up manufacturing capabilities on demand, while driving greater operational efficiency,” Vazirani said.
“To meet the growing demand, Transasia will significantly invest in R&D and manpower at the facility for its immunology products with total hiring estimated at 500 employees as of now,” he said.
The company had clocked a revenue of ₹1,300 crore in the financial year ended March, 2021.
Today’s encryption technology will be putty in the hands of those running the post-quantum world. How equipped ...
Rocketship’s Anand Rajaraman on getting pitches from places like Rameswaram and Patna
Bengaluru-based Archeron group plans to open five banks that are run entirely by AI and quantum technologies
Ably skippered by N Srinivasan, India Cements is upping its post-Covid-19 game by expanding capacity
Three-in-one: Passive debt funds come at a low cost and have high-quality portfolios. Some offer return ...
Trend in the rupee movement and Q4 earnings can give direction to the market
There is room for improvement in fund transfer options
Silver looks positive but lacks the higher volumes required to substantiate bullishness
Murder is a theme that is unlikely to darken and yellow with time, the writer Truman Capote had once said.
In her novel based on the life of Rani Jindan Kaur, author Chitra Banerjee Divakaruni crafts a hero for the ...
A domineering father, three resentful sons and a vile plan — director Dileesh Pothan, screenwriter Syam ...
Actor Adil Hussain on theatre, communal amity and citizenship in a new book about Assam and its many ...
Marketers are padded up, sponsorship deals have been struck, and campaigns are rolling out. Now let the games ...
And what marketers can possibly do to bring it back in our lives
The agency has changed form over the years but its lustre has not dimmed
Media Factory has purchased the majority stake held by Sam and Lara Balsara of Madison World in Madison Media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...